Activity Preview


Pathophysiology and Treatment of Atrial Arrhythmias in 2018

Activity Type:

  • On-Demand

Release Date: 1/6/2019

Expiration Date: 9/30/2019

  • CME: 1
  • Participation - no CE credit: 1


This core curriculum session from Heart Rhythm 2018 will provide an overview on the pathophysiology of various atrial arrhythmias, an update on pharmacologic management as well as the indications, techniques and outcomes for ablation therapy.

The session is 60 minutes in length consisting of the following 20-minute presentations:

  • Mechanisms and Pathophysiology of Atrial Fibrillation
  • Current Indications, Treatment Strategies, and Outcomes of AF Ablation
  • Multidisciplinary Care of the AF Patient and Relationship to Outcomes 

Learning Objectives

  • To review the pathophysiology of various atrial arrhythmias including atrial tachycardia, atrial flutters and atrial fibrillation.
  • To outline pharmacologic treatment options and side effects
  • To discuss fundamentals of ablation therapy including indications, mapping and ablation techniques
  • To discuss appropriate follow up and monitoring for patients with atrial arrhythmias


Laurel M. Taylor, PA, PAC. Brigham & Women's Hospital, Cardiology, Boston, MA
Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS. The Heart Group, Stevens, PA

Rutuke K. Patel, PAC. Temple University Hospital, Lansdale, PA
Scott J. Cox, MS, PAC, CEPS, CCDS. Main Line Health System, Newtown, PA
Jeroen ML. Hendriks, MS, PhD, RN. Centre for Heart Rhythm Disorders - University of Adelaide, Adelaide, Australia



This enduring material supported in part by Biosense Webster.

CME Information


The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Rhythm Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.



It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).


Laurel M. Taylor, PA, PAC. - Nothing to disclose

Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS. - Speaker's Bureau; Medtronic, Inc., St. Jude Medical.

Rutuke K. Patel, PAC. - Compensation for Services; Abbott Laboratories.

Scott J. Cox, MS, PAC, CEPS, CCDS. - Compensation for Services; ScottCare Inc,. Speaker's Bureau; St. Jude Medical.

Jeroen ML. Hendriks, MS, PhD, RN. - Nothing to Disclose


Mohammad Shenasa, MD, PhD, FHRS - Nothing to Disclose
Chloe Thomas – Nothing to Disclose
Russell Werlinich – Nothing to Disclose


Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at or submit an email message to

Access Activity